WeChat Mini Program
Old Version Features

Baseline Neutrophil-to-lymphocyte Ratio As a Predictive and Prognostic Biomarker in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Cabazitaxel Versus Abiraterone or Enzalutamide in the CARD Study

R. de Wit,C. Wuelfing,D. Castellano,G. Kramer,J. -C. Eymard,C. N. Sternberg,K. Fizazi,B. Tombal,A. Bamias,J. Carles,R. Iacovelli,B. Melichar,A. Sverrisdottir,C. Theodore,S. Feyerabend,C. Helissey, M. C. Foster,A. Ozatilgan,C. Geffriaud-Ricouard,J. de Bono

ESMO Open（2021）

Cited 17|Views15
Key words
metastatic castration-resistant prostate cancer,cabazitaxel,abiraterone,enzalutamide,neutrophil-to-lymphocyte ratio,prognostic factor
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined